Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
l-University of Illinois at Chicago-community-acquired pneumonia
- Development stage
- Unknown
- Lead developer
- University of Illinois Chicago
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
l-University of Illinois at Chicago-community-acquired pneumonia refers to a clinical research program conducted by the University of Illinois at Chicago (UIC) evaluating the comparative pharmacokinetics of the antibiotics telithromycin and azithromycin. The program specifically investigates the intrapulmonary penetration of these agents, measuring concentrations in the epithelial lining fluid (ELF) and alveolar macrophages (AM) relative to plasma levels in healthy adult subjects. Telithromycin is a ketolide antibiotic that inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, while azithromycin is a macrolide that also targets the 50S subunit. This research, typically conducted in Phase 1 pharmacokinetic trials, aims to optimize dosing strategies for the treatment of community-acquired pneumonia (CAP) by understanding the lung-to-plasma concentration ratios of these therapeutic agents.
- Brand names
- KetekZithromax
- Other names
- Telithromycin vs Azithromycin Intrapulmonary Concentrations in Healthy Adults
02
Targets
16S rRNA (16S ribosomal RNA)23S rRNA (23S ribosomal RNA)
Beyond the preview
Go deeper on l-University of Illinois at Chicago-community-acquired pneumonia.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on l-University of Illinois at Chicago-community-acquired pneumonia.